Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera-Reference-Cited by-同舟云学术

Resolution of cutaneous sarcoidosis after Janus kinase inhibitor therapy for concomitant polycythemia vera

Published:2019-04 Issue:4 Volume:5 Page:360-361
ISSN:2352-5126
Container-title:JAAD Case Reports
language:en
Short-container-title:JAAD Case Reports

Author:

Wei Jenny J.,Kallenbach Lisa R.,Kreider Maryl,Leung Thomas H.,Rosenbach Misha

Publisher

Elsevier BV

Subject

Dermatology

Reference8 articles.

1. Sarcoidosis;Valeyre;Lancet,2014

2. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera;James;Nature,2005

3. The anemia of sarcoidosis;Lower;Sarcoidosis,1988

4. JAK inhibitors in dermatology: the promise of a new drug class;Damsky;J Am Acad Dermatol,2017

5. Identification of Jak-STAT signaling involvement in sarcoidosis severity via a novel microRNA-regulated peripheral blood mononuclear cell gene signature;Zhou;Sci Rep,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sarcoidosis;Rook's Textbook of Dermatology;2024-03-19

2. JAK Inhibitor Use for the Inpatient Dermatologist;Current Dermatology Reports;2023-11-18

3. ミノサイクリンを含めた，皮膚サルコイドーシスの最新の治療;The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders;2023-10-01

4. Recent Clinical Studies on the Effects of Tumor Necrosis Factor-Alpha (TNF-α) and Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) Antibody Therapies in Refractory Cutaneous Sarcoidosis: A Systematic Review;Cureus;2023-09-08

5. Janus-kinase inhibitors in dermatology: A review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease;Indian Journal of Dermatology, Venereology and Leprology;2023-09-05